Quantcast
Last updated on April 18, 2014 at 7:29 EDT

Latest Cancer staging Stories

2014-03-05 23:25:20

Diabetic patients who develop bladder cancer after taking the drug Actos (pioglitazone) tend to have about the same number of Stage I, II, and III cancers as surgical patients who never used Actos. Raleigh, NC (PRWEB) March 05, 2014 A new published study of patients who had their bladders removed because of cancer suggests that the drug Actos may not have much effect on the growth and extent of cancer. As Cancer Monthly reports, the study, published in BMC Urology, examined the cases of...

2014-02-19 12:44:47

Cancer cell spread to the sentinel node—the lymph node to which cancer cells are most likely to spread from a primary tumor—is a risk factor for melanoma death. According to a study published in this week's PLOS Medicine by Anja Ulmer, Christoph Klein and colleagues from the Universities of Tübingen and Regensburg, Germany, the prognosis of a patient largely depends on the number of disseminated cancer cells per million lymphocytes in the sentinel node. Even very low numbers were found...

2014-02-11 04:22:13

NORTH BRUNSWICK, N.J., Feb. 11, 2014 /PRNewswire/ -- PDS Biotechnology Corp., a clinical-stage biotechnology company focused on the development of novel immunotherapy treatments for cancer and other chronic diseases, as well as novel preventive vaccines, today announced that the first patient has been successfully vaccinated with PDS0101 in a Phase 1 clinical trial in patients with cervical intraepithelial neoplasia. The trial which is being conducted at three leading gynecological...

2014-02-04 12:27:40

Program goal is improved understanding of individual risk for recurrence in patients diagnosed with early stage melanoma FRIENDSWOOD, Texas, Feb. 4, 2014 /PRNewswire/ -- Castle Biosciences Inc., a leading developer of diagnostic and prognostic tests for rare cancers, today announced the launch of an educational program dedicated to the information needs of Stage I and II skin (cutaneous) melanoma patients and their caregivers. The program kicks off with the launch of an animated...

2014-01-09 08:27:14

New CEO and Members Appointed to Board of Directors SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Avelas Biosciences announced today the closing of a $6.85 million tranche of a Series B financing round - bringing the total funds raised since inception to ~$14 million. The funds will be used to support ongoing development of the Avelas Cancer Illuminator (ACI) candidate, AVB-620, through first-in-patient study. The financing was led by founding investor, Avalon Ventures, joined by new...

2013-12-13 09:38:35

More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures – including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis, according to research from The University of Texas MD Anderson Cancer Center. Presented at a poster session at the 2013 CTRC-AACR San Antonio Breast Cancer Symposium by Carlos Barcenas, M.D., assistant professor...

2013-11-19 12:29:09

CAPE TOWN, November 19, 2013 /PRNewswire/ -- United Nations (UN) officials, Ministries of Health and leading international decision makers have come together for the first time in Africa to discuss the growing global cancer burden at the 2013 World Cancer Leaders' Summit (WCLS) which took place today at Cape Town City Hall. Organised by the Union for International Cancer Control (UICC) and hosted by the Cancer Association of South Africa (CANSA), the event is an...

2013-11-14 23:30:13

Dr. Boris Gorbunov, Director and Leading Technical Scientist of Ancon Technologies announces that only $750,000 is needed to bring the company’s ground-breaking Nanoparticle Biomarker disease detection device to the next stage where it can be tested as the world’s first breath detection device to identify very early stage Cancer as well as other diseases such as Tuberculosis before they manifest into a life threatening stage. Canterbury, Kent. United Kingdom (PRWEB) November 14, 2013...

2013-11-13 08:26:15

Journal of Clinical Oncology Publishes Positive Results from Third Successful Validation in Stage II Colon Cancer, First Validation in Patients with Stage III Disease REDWOOD CITY, Calif., Nov. 13, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) has published positive results from a large, independent validation study of the Oncotype DX(®) colon cancer test in patients from the National Surgical Adjuvant Breast and...

2013-11-12 08:36:47

Significantly Superior Early-Stage Sensitivity Shown versus CA125, Modified ACOG Guidelines or Overall Clinical Assessment in Premenopausal and Postmenopausal Women Planning Surgery WASHINGTON, Nov. 12, 2013 /PRNewswire/ -- A new study of OVA1® clinical performance in the presurgical detection of ovarian cancer, entitled "Clinical Performance of a Multivariate Index Assay For Detecting Early-Stage Ovarian Cancer," has been published in The American Journal of Obstetrics &...